Botulinum Toxin Market Forecast 2025-2030: Competitive Positioning, Strategies And Market Share Analysis

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, April 14, 2025 (GLOBE NEWSWIRE) -- The "Botulinum Toxin Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.
The Botulinum Toxins Market, valued at US$12.181 billion in 2030 from US$8.590 billion in 2025, is projected to grow at a CAGR of 7.23% through 2030.
The major growth drivers for the botulinum toxin market are the aging population, increasing numbers of minimally invasive surgeries, upsurge in facial aesthetics procedures, the rising alternative of non-surgical procedures, and advancement in innovation. This includes increasing the duration of action for Botulinum Toxin Type A, which has been an important innovation. Besides, increased healthcare spending in emerging markets is a major driving factor.
Market Trends:

• Technological advancements and new product development : Innovations in technology and promising research outcomes have motivated manufacturers to create new products for quicker adoption. For example, in September 2024, AEON Biopharma, Inc. developed a botulinum toxin complex under the 351(k) biosimilar pathway. The company received formal minutes from a Biosimilar Initial Advisory (BIA) meeting with the U.S. Food and Drug Administration (FDA) for ABP-450 (prabotulinumtoxinA) injection, a biosimilar to BOTOX (onabotulinumtoxinA).
• Rising demand for minimally invasive treatments : Botulinum toxins are increasingly used in minimally invasive procedures, a trend fueled by technological progress. Neuromodulator injections like Botox and dermal fillers have become integral to aesthetic maintenance, offering immediate results with minimal downtime. In 2023, the U.S. recorded 4,715,716 procedures using botulinum toxin type A (including Botox, Dysport, and Xeomin), marking a 6% increase from the previous year, according to the American Society of Plastic Surgeons.
• Growing market in emerging economies : Countries like China are witnessing significant demand for botulinum toxins, driven by rising disposable incomes and heightened awareness of personal appearance. This has expanded the market, as more individuals are willing to invest in cosmetic treatments.
• North America's leading role : North America remains a major consumer of botulinum toxins, with neuromodulator injections widely used to reduce wrinkles and fine lines. Soft tissue fillers are also increasingly popular for restoring volume and hydration to the skin. In 2023, cosmetic minimally invasive procedures using neuromodulator injections (Botox, Dysport, Xeomin, Jeuveau, Daxxify) reached 9,480,949, a 9% increase from the previous year. This growing demand is expected to further drive market expansion.

Some of the major players covered in this report include Ipsen Group, Allergen, Inc., Metabiologics, Merz Pharma, Galderma, AbbVie Inc., Medytox, Lanzhou Institute of Biological Products Co., Ltd., HUGEL, Inc., Evolus, Inc., Revance Therapeutics, Inc., and Supernus Pharmaceuticals, Inc., among others:
Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Key Attributes:

Report Attribute	Details
No. of Pages	150
Forecast Period	2025 - 2030
Estimated Market Value (USD) in 2025	$8.59 Billion
Forecasted Market Value (USD) by 2030	$12.18 Billion
Compound Annual Growth Rate	7.2%
Regions Covered	Global

Key Topics Covered:
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. BOTULINUM TOXINS MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Botulinum Toxin Type A
5.3. Botulinum Toxin Type B
6. BOTULINUM TOXINS MARKET BY APPLICATION
6.1. Introduction
6.2. Aesthetic Applications
6.3. Therapeutic Applications
7. BOTULINUM TOXINS MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Cosmetic Centers
8. BOTULINUM TOXINS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.3. South America
8.4. Europe
8.5. Middle East and Africa
8.6. Asia Pacific
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES

• Ipsen Group
• Metabiologics
• Merz Pharma
• Galderma
• AbbVie Inc.
• Medytox
• Lanzhou Institute of Biological Products Co., Ltd.
• HUGEL, Inc.
• Evolus, Inc.
• Revance Therapeutics, Inc.
• Supernus Pharmaceuticals, Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN14042025004107003653ID1109427936